Lord, Abbett & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
AI
THLTP
CB
Lord, Abbett & Co's SYNH Position: Q1 2021 in Review
Lord, Abbett & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2021, closing a stake of 86,300 shares — an estimated $5.88M sold.
Lord, Abbett & Co first reported a position in SYNH in Q4 2014 and held it in 14 quarters. The position peaked at $16.3M in Q3 2018. 319 funds tracked by Wall St. Rank hold SYNH as of Q1 2021.
- Lord, Abbett & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2021 after selling out during the quarter.
- Lord, Abbett & Co sold 86,300 Syneos Health, Inc. Class A Common Stock shares in Q1 2021, an estimated $5.88M.
- Lord, Abbett & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 14 quarters.
- Lord, Abbett & Co's Syneos Health, Inc. Class A Common Stock position peaked at $16.3M in Q3 2018.
- 319 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2021.
Based on Lord, Abbett & Co's 13F filing for Q1 2021, filed 11 May 2021.